
Post

Komoh
Moderna Q3 Outlook: Moderna (MRNA) is set to report its Q3 results before the US market open on Nov 6, following a net loss of approximately $800M in Q2.
Market Sentiment: Sentiment on the prediction market "Will Moderna (MRNA) beat quarterly earnings?" leans heavily optimistic, with 94% voting "Yes" against 6% for "No" on a volume of 2.61M.
#ModernaQ3VaccineSales

Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Today’s market buzz
1#Anthropic launches IPO roadshow, valuation rebounds to $1.8 trillion
Hot


2#Twenty One Capital increased its holdings by 154 BTC, marking the first time since July 2025
3#Gold fell below $3745, wiping out nearly $800 billion in market value
